ERKs activation and calcium signaling are both required for VEGF induction by vanadium in mouse epidermal Cl41 cells

Molecular and Cellular Biochemistry

Volumn 279, Issue 1-2, 2005, Pages 25-33

  Li, Jingxia ^a   Tong, Qiangsong ^a   Shi, Xianglin ^a   Costa, Max ^a   Huang, Chuanshu ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Calcium signaling; ERK; p38 kinase; PI 3K; Vanadium

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 HYDROXYPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; CALCIUM; CALCIUM CHANNEL BLOCKING AGENT; DIMETHYLBENZ[A]ANTHRACENE; MAMMALIAN TARGET OF RAPAMYCIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE P38; MUTANT PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN P85; RAPAMYCIN; TRANSCRIPTION FACTOR NFAT; VANADIUM; VASCULOTROPIN;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ARTICLE; CALCIUM CELL LEVEL; CALCIUM SIGNALING; CHEMICAL CARCINOGENESIS; CONCENTRATION RESPONSE; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME PHOSPHORYLATION; EPIDERMIS CELL; MOLECULAR MECHANICS; MOUSE; MOUSE STRAIN; NONHUMAN; PROTEIN EXPRESSION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; CALCIUM SIGNALING; CELL LINE; CHELATING AGENTS; CHROMONES; EGTAZIC ACID; ENZYME INHIBITORS; EPIDERMIS; FLAVONOIDS; MAP KINASE KINASE KINASES; MICE; MORPHOLINES; PHOSPHATIDYLINOSITOL 3-KINASES; TIME FACTORS; TRANSFECTION; VANADIUM; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

ANIMALIA; MAMMALIA;

EID: 30344476974     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-005-8212-5     Document Type: Article

References (48)

1. Crans DC, Simone CM, Saha AK, Glew RH: Vanadate monomers and dimers both inhibit the human prostatic acid phosphatase. Biochem Biophys Res Commun 165: 246-250, 1989 10.1016/0006-291X(89)91061-9
2. Nriagu JO, Pacyna JM: Quantitative assessment of worldwide contamination of air, water and soils by trace metals. Nature 333: 134-139, 1988 10.1038/333134a0
3. Barceloux DG: Vanadium. J Toxicol Clin Toxicol 37: 265-278, 1999 10382561
4. Rehder D, Costa PJ, Geraldes CF, Castro MC, Kabanos T, Kiss T, Meier B, Micera G, Pettersson L, Rangel M, Salifoglou A, Turel I, Wang D: In vitro study of the insulin-mimetic behaviour of vanadium(IV, V) coordination compounds. J Biol Inorg Chem 7: 384-396, 2002 11941496
5. Chen F, Shi X: Intracellular signal transduction of cells in response to carcinogenic metals. Crit Rev Oncol Hematol 42: 105-121, 2002 11923072
6. Smith JB: Vanadium ions stimulate DNA synthesis in Swiss mouse 3T3 and 3T6 cells. Proc Natl Acad Sci USA 80: 6162-6166, 1983
7. Rojas E, Valverde M, Herrera LA, Altamirano-Lozano M, Ostrosky-Wegman P: Genotoxicity of vanadium pentoxide evaluate by the single cell gel electrophoresis assay in human lymphocytes. Mutat Res 359: 77-84, 1996 8598834
8. Rodriguez-Mercado JJ, Roldan-Reyes E, Altamirano-Lozano M: Genotoxic effects of vanadium(IV) in human peripheral blood cells. Toxicol Lett 144: 359-369, 2003 10.1016/S0378-4274(03)00255-8
9. Chakraborty T, Ghosh S, Datta S, Chakraborty P, Chatterjee M: Vanadium suppresses sister-chromatid exchange and DNA-protein crosslink formation and restores antioxidant status and hepatocellular architecture during 2-acetylaminofluorene-induced experimental rat hepatocarcinogenesis. J Exp Ther Oncol 3: 346-362, 2003 10.1111/j.1533-869X.2003.01107.x
10. Shisheva A, Ikonomov O, Shechter Y: The protein tyrosine phosphatase inhibitor, pervanadate, is a powerful antidiabetic agent in streptozotocin-treated diabetic rats. Endocrinology 134: 507-510, 1994 10.1210/en.134.1.507
11. Kadota S, Fantus IG, Deragon G, Guyda HJ, Posner BI: Stimulation of insulin-like growth factor II receptor binding and insulin receptor kinase activity in rat adipocytes. Effects of vanadate and H2O2. J Biol Chem 262: 8252-8256, 1987 3036804
12. Montesano R, Pepper MS, Belin D, Vassalli JD, Orci L: Induction of angiogenesis in vitro by vanadate, an inhibitor of phosphotyrosine phosphatases. J Cell Physiol 134: 460-466, 1988 2450879
13. Miyoshi C, Ohshima N: Vascular endothelial growth factor (VEGF) expression regulates angiogenesis accompanying tumor growth in a peritoneal disseminated tumor model. In Vivo 15: 233-238, 2001 11491018
14. Qian D, Lin HY, Wang HM, Zhang X, Liu DL, Li QL, Zhu C: Involvement of ERK1/2 pathway in TGF-beta1-induced VEGF secretion in normal human cytotrophoblast cells. Mol Reprod Dev 68: 198-204, 2004 10.1002/mrd.20061
15. Okajima E, Thorgeirsson UP: Different regulation of vascular endothelial growth factor expression by the ERK and p38 kinase pathways in v-ras, v-raf, and v-myc transformed cells. Biochem Biophys Res Commun 270: 108-111, 2000 10.1006/bbrc.2000.2386
16. Abid MR, Guo S, Minami T, Spokes KC, Ueki K, Skurk C, Walsh K, Aird WC: Vascular endothelial growth factor activates PI3K/Akt/forkhead signaling in endothelial cells. Arterioscler Thromb Vasc Biol 24: 294-300, 2004 10.1161/01.ATV.0000110502.10593.06
17. Jiang BH, Zheng JZ, Aoki M, Vogt PK: Phosphatidylinositol 3-kinase signaling mediates angiogenesis and expression of vascular endothelial growth factor in endothelial cells. Proc Natl Acad Sci USA 97: 1749-1753, 2000 10.1073/pnas.040560897
18. 2+ and protein kinase C signaling pathway in HepG2 human hepatoblastoma cells. Int J Mol Med 7: 91-96, 2001 11115615
19. Li J, Davidson G, Huang Y, Jiang BH, Shi X, Costa M, Huang C: Nickel compounds act through hosphatidylinositol-3-kinase/Akt-dependent, p70(S6k)-independent pathway to induce hypoxia inducible factor transactivation and Cap43 expression in mouse epidermal Cl41 cells. Cancer Res 64: 94-101, 2004 10.1158/0008-5472.CAN-03-0737
20. Li J, Tang MS, Liu B, Shi X, Huang C: A critical role of PI-3K/Akt/JNKs pathway in benzo[a]pyrene diol-epoxide (B[a]PDE)-induced AP-1 transactivation in mouse epidermal Cl41 cells. Oncogene 23: 3932-3944, 2004 10.1038/sj.onc.1207501
21. Gao N, Ding M, Zheng JZ, Zhang Z, Leonard SS, Liu KJ, Shi X, Jiang BH: Vanadate-induced expression of hypoxia-inducible factor 1 alpha and vascular endothelial growth factor through phosphatidylinositol 3-kinase/ Akt pathway and reactive oxygen species. J Biol Chem 277: 31963-31971, 2002 10.1074/jbc.M200082200
22. Senger DR, Van de Water L, Brown LF, Nagy JA, Yeo KT, Yeo TK, Berse B, Jackman RW, Dvorak AM, Dvorak HF: Vascular permeability factor (VPF, VEGF) in tumor biology. Cancer Metastasis Rev 12: 303-324, 1993 8281615
23. Hazzalin CA, Mahadevan LA: MAPK-regulated transcription: a continuously variable gene switch? Nat Rev Mol Cell Biol 3: 30-40, 2002
24. 2+]i inhibits hypoxia-induced vascular permeability factor (vascular endothelial growth factor) gene expression. Biochem Biophys Res Commun 229: 733-738, 1996 10.1006/bbrc.1996.1873
25. Krasilnikov MA: Phosphatidylinositol-3 kinasT dependent pathways: the role in control of cell growth, survival, and malignant transformation. Biochemistry (Mosc) 65: 59-67, 2000
26. El-Hashemite N, Walker V, Zhang H, Kwiatkowski DJ: Loss of Tsc1 or Tsc2 induces vascular endothelial growth factor production through mammalian target of rapamycin. Cancer Res 63: 5173-5177, 2003
27. Nemery B: Metal toxicity and the respiratory tract. Eur Respir J 3: 202-219, 1990 2178966
28. Stern A, Yin X, Tsang SS, Davison A, Moon J: Vanadium as a modulator of cellular regulatory cascades and oncogene expression. Biochem Cell Biol 71: 103-112, 1993 8398067
29. Sabbioni E, Pozzi G, Devos S, Pintar A, Casella L, Fischbach M: The intensity of vanadium(V)-induced cytotoxicity and morphological transformation in BALB/3T3 cells is dependent on glutathione-mediated bioreduction to vanadium(IV). Carcinogenesis 14: 2565-2568, 1993 8269628
30. Ress NB, Chou BJ, Renne RA, Dill JA, Miller RA, Roycroft JH, Hailey JR, Haseman JK, Bucher JR: Carcinogenicity of inhaled vanadium pentoxide in F344/N rats and B6C3F1 mice. Toxicol Sci 74: 287-296, 2003 10.1093/ toxsci/kfg136
31. Fu BM, Shen S: Structural mechanisms of acute VEGF effect on microvessel permeability. Am J Physiol Heart Circ Physiol 284: H2124-2135, 2003 12560209
32. Leenders W, van Altena M, Lubsen N, Ruiter D, De Waal R: In vivo activities of mutants of vascular endothelial growth factor (VEGF) with differential in vitro activities. Int J Cancer 91: 327-333, 2001 10.1002/ 1097-0215(200002)9999:9999<::AID-IJC1052>3.3.CO;2-N
33. Ferrara N: VEGF: An update on biological and therapeutic aspects. Curr Opin Biotechnol 11: 617-624, 2000 11102799
34. Inoue M, Hager JH, Ferrara N, Gerber HP, Hanahan D: VEGF-A has a critical, nonredundant role in angiogenic switching and pancreatic beta cell carcinogenesis. Cancer Cell 1: 193-202, 2002 10.1016/ S1535-6108(02)00031-4
35. Gannon G, Mandriota SJ, Cui L, Baetens D, Pepper MS, Christofori G: Overexpression of vascular endothelial growth factor-A165 enhances tumor angiogenesis but not metastasis during beta-cell carcinogenesis. Cancer Res 62: 603-608, 2002 11809716
36. Wang G, Dong Z, Xu G, Yang Z, Shou C, Wang N, Liu T: The effect of antibody against vascular endothelial growth factor on tumor growth and metastasis. J Cancer Res Clin Oncol 124: 615-620, 1998 10.1007/ s004320050223
37. Konishi T, Huang CL, Adachi M, Taki T, Inufusa H, Kodama K, Kohno N, Miyake M: The K-ras gene regulates vascular endothelial growth factor gene expression in non-small cell lung cancers. Int J Oncol 16: 501-511, 2000 10675482
38. Fontanini G, Boldrini L, Vignati S, Chine S, Basolo F, Silvestri V, Lucchi M, Mussi A, Angeletti CA, Bevilacqua G: Bcl2 and p53 regulate vascular endothelial growth factor (VEGF)-mediated angiogenesis in non-small cell lung carcinoma. Eur J Cancer 34: 718-723, 1998 10.1016/ S0959-8049(97)10145-9
39. Milanini J, Vinals F, Pouysségur J, Pagès G: P42/p44 MAP kinase module plays a key role in the transcriptional regulation of the vascular endothelial growth factor gene in fibroblasts. J Biol Chem 273: 18165-18172, 1998 10.1074/jbc.273.29.18165
40. Rak J, Mitsuhashi Y, Sheehan C, Tamir A, Viloria-Petit A, Filmus J, Mansour SJ, Ahn NG, Kerbel RS: Oncogenes and tumor angiogenesis: differential modes of vascular endothelial growth factor up-regulation in ras-transformed epithelial cells and fibroblasts. Cancer Res 60: 490-498, 2000 10667605
41. Berra E, Pages G, Pouyssegur J: MAP kinases and hypoxia in the control of VEGF expression. Cancer Metastasis Rev 9: 139-145, 2000 10.1023/ A:1026506011458
42. Mottet D, Michel G, Renard P, Ninane N, Raes M, Michiels C: Role of ERK and calcium in the hypoxia-induced activation of HIF-1. J Cell Physiol 194: 30-44, 2003 10.1002/jcp.10176
43. Alfranca A, Gutierrez MD, Vara A, Aragones J, Vidal F, Landazuri MO: c-Jun and hypoxia-inducible factor 1 functionally cooperate in hypoxia-induced gene transcription. Mol Cell Biol 22: 12-22, 2002 10.1128/MCB.22.1.12-22.2002
44. Zhang Z, Leonard SS, Huang C, Vallyathan V, Castranova V, Shi X: Role of reactive oxygen species and MAPKs in vanadate-induced G(2)/M phase arrest. Free Radic Biol Med 34: 1333-1342, 2003 10.1016/ S0891-5849(03)00145-X
45. Venkatachalam K, van Rossum DB, Patterson RL, Ma HT, Gill DL: The cellular and molecular basis of store-operated calcium entry. Nat Cell Biol 4: E263-272, 2002 10.1038/ncb1102-e263
46. Arnould T, Michiels C, Alexandre I, Remacle J: Effect of hypoxia upon intracellular calcium concentration of human endothelial cells. J Cell Physiol 152: 215-221, 1992 10.1002/jcp.1041520127
47. Leissring MA, Parker I, LaFerla FM: Presenilin-2 mutations modulate amplitude and kinetics of inositol 1,4,5-trisphosphate-mediated calcium signals. J Biol Chem 274: 32535-32538, 1999 10.1074/jbc.274.46.32535
48. 2+ in hypoxia-induced gene expression in human hepatoma cells (Hep3B). J Physiol 517: 651657, 1999 10.1111/ j.1469-7793.1999.0651s.x